Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) — The “India Malaria Vaccine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The India Malaria Vaccine Market was valued at USD 38.21 Million in 2024, and is expected to reach USD 47.21 Million by 2030, rising at a CAGR of 3.59%
The Rising awareness among people for early detection and treatments coupled with the rising number of people suffering from malaria are expected to augment the growth of the India malaria vaccine market. Malaria is caused by a parasite called Plasmodium, which is transmitted to humans through the bites of infected mosquitoes.
Malaria is preventable and treatable, but the development of effective vaccines is essential to control and ultimately eliminate this disease. Growing incidences of malaria in the country is a major factor, which is surging the demand for effective malaria vaccines. These malaria vaccines are vaccines that are designed to prevent or reduce the severity of malaria, a disease caused by parasites that are transmitted to humans through the bites of infected mosquitoes.
Furthermore, there are various other factors which are supporting the growth of India malaria vaccine market such as growing government initiatives, affordable vaccines, rising advancements in biotechnology, and others.
Route of Administration Insights
Based on the route of administration, the intramuscular category is currently dominating the India malaria vaccine market due to several key advantages it offers in terms of efficacy, ease of administration, and acceptance among healthcare professionals. Intramuscular injections allow for better absorption of vaccines compared to subcutaneous or oral routes, which is crucial for ensuring a robust immune response, especially for complex vaccines like those targeting malaria. In addition, the intramuscular route is familiar to healthcare providers across India, making it easier to implement at scale.
IM injections are also widely used in existing vaccination programs, providing a sense of standardization that helps ensure smooth integration into national immunization efforts. As malaria vaccination campaigns continue to expand, the familiarity and simplicity of administering vaccines via the IM route are expected to play a pivotal role in encouraging adoption by healthcare professionals and the public. Furthermore, the consistent success of other vaccines delivered intramuscularly in India helps maintain trust in the safety and effectiveness of this administration method for malaria vaccines.
Regional Insights
Based on the region, East India was dominating in India Vaccine Market in 2024. East India, comprising states like West Bengal, Odisha, Bihar, and Assam, is experiencing a significant malaria burden, making it a key region for the malaria vaccine market. These states are known for having high transmission rates of malaria, with large populations living in areas prone to endemic transmission. The prevalence of malaria in these regions, particularly among vulnerable populations such as children and pregnant women, has made it a priority for both government and public health organizations to implement effective prevention strategies, including vaccination.
The demand for malaria vaccines is therefore high in East India, where targeted interventions are necessary to control and reduce malaria incidence. The geographical factors and environmental conditions in these states, such as monsoons and high humidity, create ideal breeding grounds for malaria-carrying mosquitoes, exacerbating the disease burden and increasing the urgency of vaccination programs. Consequently, East India’s substantial malaria cases have made it the dominant market for malaria vaccines in the country, driving efforts to prioritize vaccine distribution and ensure timely access.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $38.21 Million |
| Forecasted Market Value (USD) by 2030 | $47.21 Million |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | India |
Report Scope:
Key Market Players
- Gennova Biopharmaceuticals Ltd
- Zydus Group
- Serum Institute of India Private Limited
- Bharat Biotech International Limited
- Indian Immunologicals Limited, Inc.
- Panacea Biotec
- Mynvax
- Cadila Pharmaceuticals
- Biological E Limited
- Sanofi Pasteurs Health
India Malaria Vaccine Market, By Vaccine Type:
- Pre-Erythrocytic
- Erythrocytic
- Multi-antigen
- Others
India Malaria Vaccine Market, By Route of Administration:
- Intramuscular
- Subcutaneous
- Intradermal
- Others
India Malaria Vaccine Market, By Region:
- North India
- South India
- East India
- West India
For more information about this report visit https://www.researchandmarkets.com/r/g7ab7g
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Indian Malaria Vaccine Market
